tiprankstipranks
Van Elle Holdings PLC (GB:VANL)
LSE:VANL

Van Elle Holdings (VANL) Income Statement

0 Followers

Van Elle Holdings Income Statement

Last quarter (Q2 2023), Van Elle Holdings's total revenue was £―, a decrease of ― from the same quarter last year. In Q2, Van Elle Holdings's net income was £―. See Van Elle Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Apr 23Apr 22Apr 21Apr 20Apr 19
Total Revenue
-£ 148.73M£ 124.92M£ 84.37M£ 84.37M£ 88.47M
Cost of Revenue
-£ 108.65M£ 90.84M£ 62.37M£ 61.79M£ 60.28M
Gross Profit
-£ 40.09M£ 34.07M£ 22.00M£ 22.58M£ 28.19M
Operating Expense
-£ 34.19M£ 29.40M£ 22.88M£ 23.89M£ 23.47M
Operating Income
-£ 5.90M£ 4.67M£ -872.00K£ -1.31M£ 4.72M
Net Non Operating Interest Income Expense
-£ -440.00K£ -718.00K£ -598.00K£ -630.00K£ -527.00K
Other Income Expense
-£ 47.00K£ 61.00K---
Pretax Income
-£ 5.37M£ 3.73M£ -1.40M£ -2.24M£ 4.04M
Tax Provision
-£ 693.00K£ 1.73M£ 13.00K£ 216.00K£ 823.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ 4.68M£ 2.00M£ -1.41M£ -2.46M£ 3.21M
Basic EPS
-£ 0.04£ 0.02£ -0.01£ -0.03£ 0.04
Diluted EPS
-£ 0.04£ 0.02£ -0.01£ -0.03£ 0.04
Basic Average Shares
-£ 106.67M£ 106.67M£ 106.67M£ 81.53M£ 80.00M
Diluted Average Shares
-£ 107.14M£ 106.67M£ 106.67M£ 81.53M£ 80.00M
Dividend Per Share
-£ 0.01£ 0.01£ 0.00£ 0.01£ 0.03
Total Operating Income As Reported
------
Reported Normalized Basic E P S
---£ -0.01£ -0.01£ 0.05
Reported Normalized Diluted E P S
---£ -0.01£ -0.01£ 0.05
Rent Expense Supplemental
---£ 3.91M£ 3.12M£ 2.92M
Total Expenses
-£ 142.83M£ 120.24M£ 85.24M£ 85.68M£ 83.75M
Net Income From Continuing And Discontinued Operation
-£ 4.68M£ 2.00M£ -1.41M£ -2.46M£ 3.21M
Normalized Income
-£ 4.40M£ 3.18M£ -1.47M£ -2.21M£ 3.34M
Interest Expense
---£ 607.00K£ 654.00K£ 579.00K
EBIT
-£ 5.81M£ 4.45M£ -792.00K£ -1.58M£ 4.61M
EBITDA
-£ 11.94M£ 9.84M£ 4.19M£ 3.04M£ 8.95M
Currency in GBP

Van Elle Holdings Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis